Document is current
Any future updates will be listed below
-
Authors
Nonaka, Toshihiro https://orcid.org/0009-0006-0261-5959
Murata, Daiki https://orcid.org/0000-0003-0201-0205
Yoshizato, Hiromu https://orcid.org/0009-0004-7933-3744
Kashimoto, Shohei https://orcid.org/0009-0000-2941-0116
Nakamura, Anna https://orcid.org/0000-0003-3903-0306
Morimoto, Tadatsugu https://orcid.org/0000-0002-3359-9684
Nakayama, Koichi https://orcid.org/0000-0002-7324-8862
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (22K09383, 22K09383, 22K09383, 22K09383, 22K09383)
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 11 February 2025
First Online: 20 February 2025
Declarations
:
: The animal studies were performed after receiving approval from the Institutional Animal Care and Use Committee of Saga University (Application No. A2022-048-0).
: Not applicable.
: K.N. is a cofounder and shareholder of Cyfuse Biomedical KK, Chief Technical Officer of Arktus Therapeutics, and an inventor/developer designated on the patent for the bio-3D printer. Patent title: Method for Production of Three-Dimensional Structure of Cells; patent number: JP4517125. Patent title: Cell structure production device; patent number: JP5896104. The other authors declare that they have no competing interests with respect to the publication of this article.
